LOSS OF THE TIGHT JUNCTION PROTEINS OCCLUDIN AND ZONULA OCCLUDENS-1 FROM CEREBRAL VASCULAR ENDOTHELIUM DURING NEUTROPHIL-INDUCED BLOOD-BRAIN-BARRIER BREAKDOWN IN-VIVO
Sj. Bolton et al., LOSS OF THE TIGHT JUNCTION PROTEINS OCCLUDIN AND ZONULA OCCLUDENS-1 FROM CEREBRAL VASCULAR ENDOTHELIUM DURING NEUTROPHIL-INDUCED BLOOD-BRAIN-BARRIER BREAKDOWN IN-VIVO, Neuroscience, 86(4), 1998, pp. 1245-1257
The tight junctions found between cerebral vascular endothelial cells
form the basis of the blood-brain barrier. Breakdown of the blood-brai
n barrier is a feature of a variety of CNS pathologies that are charac
terized by extensive leucocyte recruitment, such as multiple sclerosis
and stroke. The molecular mechanisms associated with opening of the b
lood-brain barrier and leucocyte recruitment in vivo are currently poo
rly understood. We have used an in vivo rat model to investigate the m
olecular response of the CNS endothelium to neutrophil adhesion and mi
gration. Injection of interleukin-1 beta into the striatum of juvenile
brains results in a neutrophil-dependent increase in vessel permeabil
ity at 4 h. Only a subset of blood vessels were associated with neutro
phil recruitment. These particular Vessels displayed an increase in ph
osphotyrosine staining, loss of the tight junctional proteins, occludi
n and zonula occludens-1, and apparent redistribution of the adherens
junction protein vinculin. Examination of these vessels under the elec
tron microscope indicated that the cell-cell adhesions in such vessels
are morphologically different from normal junctions. This study provi
des the first direct evidence ill vivo that leucocyte recruitment can
trigger signal transduction cascades leading to junctional disorganiza
tion and blood-brain barrier breakdown. Our results have established a
n endothelial cell molecular profile associated with leucocyte-induced
blood-brain barrier breakdown in vivo, and the relevance of different
in vitro cell culture models may now be viewed more objectively. (C)
1998 IBRO. Published by Elsevier Science Ltd.